FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096779 [Registered on: 03/11/2025] Trial Registered Prospectively
Last Modified On: 01/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical study to evaluate the efficacy of COMPOUND UNANI FORMULATION JAWARISH-E-TABASHEER in GERD 
Scientific Title of Study   A RANDOMISED TWO ARM ACTIVE CONTROLLED CLINICAL STUDY OF GASTRO ESOPHAGEAL REFLUX DISEASE (MARZ-E-INEKAS-E-HUMUZAT-E-MEDA WO MARI ) WITH COMPOUND UNANI FORMULATION JAWARISH-E-TABASHEER AND RABEPRAZOLE 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amreen 
Designation  PG scholar 
Affiliation  Government Nizamia Tibbi College and Hospital 
Address  Government Nizamia Tibbi College OP No 1 PG Department of Moalijat Government Nizamia Tibbi College and General Hospital Charminar Hyderabad TELANGANA 500002 India

Hyderabad
TELANGANA
500002
India 
Phone  7569687151  
Fax    
Email  dramreen1221@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Syed Abdul Khadir Hussaini 
Designation  Professor 
Affiliation  Government Nizamia Tibbi College and Hospital 
Address  Government Nizamia Tibbi College Room no 215 and OP No 1 PG Department of Moalijat, Government Nizamia Tibbi College and General Hospital, Charminar Hyderabad Hyderabad TELANGANA 500002 India

Hyderabad
TELANGANA
500002
India 
Phone  9704888561  
Fax    
Email  drsakhussaini@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amreen 
Designation  PG scholar 
Affiliation  Government Nizamia Tibbi College and Hospital 
Address  Government Nizamia Tibbi College OP No 1 PG Department of Moalijat Government Nizamia Tibbi College and General Hospital Charminar. Hyderabad TELANGANA 500002 India

Hyderabad
TELANGANA
500002
India 
Phone  7569687151  
Fax    
Email  dramreen1221@gmail.com  
 
Source of Monetary or Material Support  
Government Nizamia Tibbi College and General Hospital ,Charminar,Hyderabad  
 
Primary Sponsor  
Name  PG Scholar Dept of Moalijat 
Address  Government Nizamia Tibbi College and Hospital OP No 1 PG Department of Moalijat Government Nizamia Tibbi College and General Hospital Charminar Hyderabad Hyderabad TELANGANA 500002 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amreen  Government Nizamia Tibbi College  Government Nizamia Tibbi College OP No 1 PG Department of Moalijat Government Nizamia Tibbi College and General Hospital Charminar. Hyderabad TELANGANA 500002 India
Hyderabad
TELANGANA 
07569687151

dramreen1221@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K00-K95||Diseases of the digestive system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  JAWARISH E TABSHEER  5GMS BD WITH ARQ BADYAN 150ML AFTER MEALS WITH TWO FOLLOW UPS WITH INTERVAL OF 15 DAYS 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  RABEPRAZOLE  20MG OD BEFORE MEALS FOR 30 DAYS WITH 2 FOLLOW UPS WITH AN INTERVAL OF 15 DAYS 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient of either sex
Age : 20-60 years.
Patient with following complains :Regurgitation, Heart burn, Epigastric Pain,Nausea ,Indigestion,Flatulence,Loss of appetite, Water brash, Heaviness in abdomen after meals.
 
 
ExclusionCriteria 
Details  Pregnant and lactating women
Psychiatric patients
Uncontrolled diabetes
GERD due to LOS causes .
Patients with cardiac, respiratory, liver and renal dysfunction.
Patients with:
Bleeding disorders
Known peptic ulcers
Gastric carcinoma
Hiatus hernia
Crohn’s disease
Zollinger Ellison Syndrome
Esophageal strictures, stenosis
Other malignancies
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to evaluate the clinical efficacy of jawarish e tabasheer in cases of GERD  once in 2-4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To prevent from complications of GERD like peptic strictures, Barret’s esophagus, esophageal adenocarcinoma.  Once in Two weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

GERD (Gastroesophageal Reflux Disease):

GERD is a chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and inflammation. This occurs due to weakness or relaxation of the lower esophageal sphincter (LES).

Key Symptoms are :-Heartburn (burning chest pain), Regurgitation of food or sour fluid, Bloating, belching, Difficulty swallowing, Chronic cough or sore throat

Jawarish-e-Tabasheer is a classical Unani formulation traditionally used for strengthening the digestive system and reducing excess heat and bile (Safra).

Since the  chronic use of PPIs in the management of GERD cause hypomagnesemia,osteoporosis ;the efficacy of unani drug JAWARISH E TABASHEER is evaluated

 
Close